No­var­tis re­sumes re­mote busi­ness in Ukraine af­ter safe­ty pro­to­col re­view

Months af­ter a slate of phar­ma com­pa­nies slammed the brakes on some op­er­a­tions in both Rus­sia and Ukraine, No­var­tis an­nounced that it’s re­sum­ing busi­ness re­mote­ly in Ukraine “to help the war-torn coun­try re­store some ba­sic crit­i­cal busi­ness process­es.”

No­var­tis came to the de­ci­sion af­ter study­ing safe­ty pro­to­cols and re­ceiv­ing ad­vice “which we will reg­u­lar­ly re­view,” the com­pa­ny said on Wednes­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER